drugset / Trial / NCT02807298

4% Articaine and 2% Lidocaine by Intraligamentary Technique in Irreversible Pulpitis

NCT02807298

Phase 3 Completed 25 enrolled Dr. D. Y. Patil Dental College & Hospital
RandomizedCrossoverDouble-blindTreatment

Summary

This study compared the anesthetic efficacy between Lignocaine and articaine administering it intraligamentarly using ligajet in twenty five female patients having irreversible pulpitis on bilateral mandibular molars. At 5minutes of post injection, the teeth were isolated with rubber dam and access performed. Patients were instructed to definitively rate any pain felt during endodontic procedure. If patient felt pain, the treatment was immediately stopped and the patient rated their discomfort using Heft Parker VAS. The extent of access achieved when the patient felt pain was recorded as within dentin, entering the pulp chamber or initial file placement. The success was defined as the ability to access and instrument the tooth without pain (VAS score of zero) or mild pain (VAS rating\<54mm).

Timeline

Start
2014-06
Primary completion
2014-10
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Articaine Other / unclassified 0.9 ml Other
Subject Articaine Other / unclassified 4 % Other
Comparator Lidocaine Other / unclassified 1.8 ml Other
Comparator Lidocaine Other / unclassified 2 % Other
Background Epinephrine Other / unclassified Other

Indications